Pharma Show

About this Podcast...

In this podcast Mark Hembarsky, Vice President and Site Leader of the Aptuit Medicines Research Centre in Verona, Italy, and his colleagues Mauro Corsi, Head of Assay Development and In Vitro Profiling Preclinical Technologies, Sergio Raimondo, Head of Scientific Strategy Preclinical Safety, Phil Gerrard Head of Preclinical Pharmacology and Stefano Zancan, Head of Clinical Trial Management, join Andrea Charles from Pharma IQ, to share their scientific and technological expertise and provide an insight into the Aptuit Medicines Research Centre.

In this interview they discuss improving the success rates of therapeutic candidates in clinical development, making more efficient go/no-go decisions, challenges and investment considerations for biomarkers in early clinical development and the changing dynamics of the sponsor-CRO relationship.

  Have Your Say
Rate this feature and give us your feedback in the comments section below


 

Rate this Podcast: (4.4 Stars | 16 Votes)

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.

To view this FREE whitepaper, register as a Pharma IQ member below.
Or if you're already a Pharma IQ member, sign in to register.

First Name*
Last Name*
E-mail*
Phone*
Job Title*
Company
Country
State
User Name
Password
Confirm Password

By clicking Submit, you accept our User Agreement, Privacy Policy, and Cookie Policy.

comments powered by Disqus


Advertise With Us

Join the Pharmas IQ Community